JEADV ARTICLES

Categories: General

Pitfalls of possible reporting of same patients with COVID-19 in various dermatology journals

Kluger N.

Categories: General

SARS-CoV, Mers-CoV and Covid-19: : what differences from a dermatological viewpoint?

Rongioletti F.

Categories: General

Position statement of the European Academy of Dermatology and Venereology Task Force on Quality of Life and Patient Oriented Outcomes on quality of life issues in dermatologic patients during the COVID-19 pandemic

Chernyshov PV, Tomas-Aragones L, Augustin M, Svensson A, Bewley A, Poot F, Szepietowski JC, Marron SE, Manolache L, Pustisek N, Suru A, Salavastru CM, Blome C, Salek MS, Abeni D, Sampogna F, Dalgard F, Linder D, Ewers A, Finlay AY.

Categories: General

Anti-androgens may protect against severe COVID-19 outcomes: results from a prospective cohort study of 77 hospitalized men

Goren A, Wambier CG, Herrera S, McCoy J, Vaño-Galván S, Gioia F, Comeche B, Ron R, Serrano-Villar S, Ramos PM, Cadegiani FA, Kovacevic M, Tosti A, Shapiro J, Sinclair R.

Categories: General

Androgen Receptor Genetic Variant Predicts COVID-19 Disease Severity: A Prospective Longitudinal Study of Hospitalized COVID-19 Male Patients

McCoy J, Wambier CG, Herrera S, Vaño-Galván S, Gioia F, Comeche B, Ron R, Serrano-Villar S, Iwasiow RM, Tayeb MA, Cadegiani FA, Mesinkovska NA, Shapiro J, Sinclair R, Goren A.

Categories: General

SARS-CoV-2 spike protein in a chilblain-like skin lesion is present in both endothelial and eccrine cells

T. Gambichler, J. Reuther, M. Stücker, R. Stranzenbach, C. Torres‐Reyes, R. Schlottmann, W.E. Schmidt, R. Hayajneh, A. Sriram, J.C. Becker

Categories: General

Cross-country comparisons of Google searches for chilblains before and during the COVID-19 pandemic

Categories: General

Not all that glitters is COVID-19: a case-series demonstrating the need for histopathology when skin findings accompany SARS-CoV-2 infection

A Barrera-Godínez, S Méndez-Flores, M Gatica-Torres, A Rosales-Sotomayor, KI Campos-Jiménez, DM Carrillo-Córdova, MC Durand-Muñoz, GL Mena-Hernández, YK Melchor-Mendoza, AL Ruelas-Villavicencio, A García-Irigoyen, GA Acatitla-Acevedo, S Toussaint-Caire, J Domínguez-Cherit

Categories: General

SARS-CoV-2: skin diseases, mask wearing and unpleasant sensations

B Cribier, C Taieb, M Saint Aroman, J Shourick

Categories: Guidelines and recommendations

European Task Force on Atopic Dermatitis (ETFAD) statement on severe acute respiratory syndrome coronavirus 2 (SARS‐Cov‐2)‐infection and atopic dermatitis.

Wollenberg A, Flohr C, Simon D, Cork MJ, Thyssen JP, Bieber T, de Bruin-Weller MS, Weidinger S, Deleuran M, Taieb A, Paul C, Trzeciak M, Werfel T, Seneschal J, Barbarot S, Darsow U, Torrelo A, Stalder JF, Svensson Å, Hijnen D, Gelmetti C, Szalai Z, Gieler U, De Raeve L, Kunz B, Spuls P, von Kobyletzki LB, Fölster-Holst R, Chernyshov PV, Cristen-Zaech S, Heratizadeh A, Ring J, Vestergaard C

Categories: Guidelines and recommendations

European Task Force on Contact Dermatitis statement on coronavirus 19 disease (COVID-19) outbreak and the risk of adverse cutaneous reactions.

Balato A, Ayala F, Bruze M, Crepy MN, Gonçalo M, Duus Johansen J, John SM, Pigatto P, Raimondo A, Rustemeyer T, Schuttelaar MA, Svedman C, Aerst O, Uter W, Wilkinson M, Gimenez-Arnau A.

Categories: Guidelines and recommendations

Expert recommendations for the management of autoimmune bullous diseases during the COVID-19 pandemic.

Kasperkiewicz M, Schmidt E, Fairley JA, Joly P, Payne AS, Yale ML, Zillikens D, Woodley DT.

Categories: Guidelines and recommendations

Management of primary cutaneous lymphoma patients during COVID-19 pandemic: EORTC CLTF guidelines.

Papadavid E, Scaribrick J, Ortiz Romero P, Guaglino P, Vermeer M, Knobler R, Stadler R, Bagot M.

Categories: Guidelines and recommendations

European Task Force on Atopic Dermatitis: position on vaccination of adult patients with atopic dermatitis against COVID‐19 (SARS‐CoV‐2) being treated with systemic medication and biologics

J.P. Thyssen C. Vestergaard S. Barbarot M.S. de Bruin‐Weller T. Bieber A. Taieb J. Seneschal M.J. Cork C. Paul C. Flohr S. Weidinger M. Trzeciak T. Werfel A. Heratizadeh U. Darsow D. Simon A. Torrelo P.V. Chernyshov J.‐F. Stalder C. Gelmetti Z. Szalai Å. Svensson L.B. von Kobyletzki L. De Raeve R. Fölster‐Holst S. Christen‐Zaech D.J. Hijnen U. Gieler J. Gutermuth C. Bangert P.I. Spuls B. Kunz J. Ring A. Wollenberg M. Deleuran

Categories: Guidelines and recommendations

Updated international expert recommendations for the management of autoimmune bullous diseases during the COVID-19 pandemic

M. Kasperkiewicz E. Schmidt M. Amagai J.A. Fairley P. Joly D.F. Murrell A.S. Payne M.L. Yale D. Zillikens D.T. Woodley

Categories: Guidelines and recommendations

Position statement of the EADV Melanoma Task Force on recommendations for the management of cutaneous melanoma patients during COVID-19

M. Arenbergerova A. Lallas E. Nagore L. Rudnicka A. Forsea M. Pasek F. Meier K. Peris J. Olah C. Posch

Categories: Cutaneous manifestations of COVID-19

Cutaneous manifestations in COVID‐19: a first perspective.

Recalcati, S.

Categories: Cutaneous manifestations of COVID-19

Comment on: Cutaneous manifestations in COVID-19: a first perspective. Safety concerns of clinical images and skin biopsies.

Fernandez-Nieto D, Ortega-Quijano D, Segurado-Miravalles G, Pindado-Ortega C, Prieto-Barrios M, Jimenez-Cauhe J.

Categories: Cutaneous manifestations of COVID-19

Comment on "Cutaneous manifestations in COVID-19: a first perspective " by Recalcati S.

Hedou M, Carsuzaa F, Chary E, Hainaut E, Cazenave-Roblot F, Masson Regnault M.

Categories: Cutaneous manifestations of COVID-19

Cutaneous manifestations in COVID-19: a new contribution.

Estébanez A, Pérez-Santiago L, Silva E, Guillen-Climent S, García-Vázquez A, Ramón MD.

Categories: Cutaneous manifestations of COVID-19

COVID-19 and cutaneous manifestations.

Mungmungpuntipantip R, Wiwanitkit V.

Categories: Cutaneous manifestations of COVID-19

A distinctive skin rash associated with Coronavirus Disease 2019?

Mahé A, Birckel E, Krieger S, Merklen C, Bottlaender L.

Categories: Cutaneous manifestations of COVID-19

Urticarial eruption in COVID-19 infection.

Henry D, Ackerman M, Sancelme E, Finon A, Esteve E.

Categories: Cutaneous manifestations of COVID-19

Viral exanthem in COVID-19, a clinical enigma with biological significance.

Su CJ, Lee CH.

Categories: Cutaneous manifestations of COVID-19

Cutaneous manifestation of COVID-19 in images: A case report.

Avellana Moreno R, Villa E, Avellana Moreno V, Estela Villa C, Aparicio M, Fontanella A.

Categories: Cutaneous manifestations of COVID-19

Cutaneous manifestations in COVID-19: the experiences of Barcelona and Rome.

Tammaro A, Adebanjo GAR, Parisella FR, Pezzuto A, Rello J.

Categories: Cutaneous manifestations of COVID-19

Acute urticaria with pyrexia as the first manifestations of a COVID-19 infection.

van Damme C, Berlingin E, Saussez S, Accaputo O.

Categories: Cutaneous manifestations of COVID-19

Did Whatsapp® reveal a new cutaneous COVID-19 manifestation?

Duong TA, Velter C, Rybojad M, Comte C, Bagot M, Sulimovic L, Bouaziz JD.

Categories: Cutaneous manifestations of COVID-19

Acral cutaneous lesions in the time of COVID-19.

Recalcati S, Barbagallo T, Frasin LA, Prestinari F, Cogliardi A, Provero MC, Dainese E, Vanzati A, Fantini F.

Categories: Cutaneous manifestations of COVID-19

SARS-CoV-2 infection presenting as a febrile rash.

Amatore F, Macagno N, Mailhe M, Demarez B, Gaudy-Marqueste C, Grob JJ, Raoult D, Brouqui P, Richard MA.

Categories: Cutaneous manifestations of COVID-19

Chilblain-like lesions during COVID-19 epidemic: a preliminary study on 63 patients.

Piccolo V, Neri I, Filippeschi C, Oranges T, Argenziano G, Battarra VC, Berti S, Manunza F, Belloni Fortina A, Di Lernia V, Boccaletti V, De Bernardis G, Brunetti B, Mazzatenta C, Bassi A.

Categories: Cutaneous manifestations of COVID-19

Symmetric cutaneous vasculitis in COVID-19 pneumonia.

Castelnovo L, Capelli F, Tamburello A, Maria Faggioli P, Mazzone A.

Categories: Cutaneous manifestations of COVID-19

Vascular skin symptoms in COVID-19: a french observational study.

Bouaziz JD, Duong T, Jachiet M, Velter C, Lestang P, Cassius C, Arsouze A, Domergue Than Trong E, Bagot M, Begon E, Sulimovic L, Rybojad M.

Categories: Cutaneous manifestations of COVID-19

Histological pattern in Covid-19 induced viral rash.

Zengarini C, Orioni G, Cascavilla A, Horna Solera C, Fulgaro C, Misciali C, Patrizi A, Gaspari V.

Categories: Cutaneous manifestations of COVID-19

Acro-ischemia in hospitalized COVID-19 patients.

Suarez-Valle A, Fernandez-Nieto D, Diaz-Guimaraens B, Dominguez-Santas M, Carretero I, Perez-Garcia B.

Categories: Cutaneous manifestations of COVID-19

Pityriasis rosea as a cutaneous manifestation of COVID-19 infection.

Ehsani AH, Nasimi M, Bigdelo Z.

Categories: Cutaneous manifestations of COVID-19

The use of Google trends for acral symptoms during COVID-19 outbreak in France.

Kluger N, Scrivener Y.

Categories: Cutaneous manifestations of COVID-19

Drug-induced vasculitis in a patient with COVID-19.

Ramirez AV, Efe D, Fischer M.

Categories: Cutaneous manifestations of COVID-19

A late onset widespread skin rash in a previous Covid-19 infected patient: viral or multidrug effect?

Skroza N, Bernardini N, Balduzzi V, Mambrin A, Marchesiello A, Michelini S, Tolino E, Proietti I, Di Cristofano C, Petrozza V, Potenza C.

Categories: Cutaneous manifestations of COVID-19

Atypical erythema multiforme palmar plaques lesions due to Sars-Cov-2.

Janah H, Zinebi A, Elbenaye J.

Categories: Cutaneous manifestations of COVID-19

Urticarial eruption in Coronavirus Disease 2019 (COVID-19) infection: a case report in Tangerang, Indonesia.

Gunawan C, Angela, Widysanto A.

Categories: Cutaneous manifestations of COVID-19

A clinicopathological study of 8 patients with COVID-19 pneumonia and a late-onset exanthema.

Herrero-Moyano M, Capusan TM, Andreu-Barasoain M, Alcántara-González J, Ruano-Del Salado M, Sánchez-Largo Uceda ME, Calzado-Villarreal L, Pérez-González Y.

Categories: Cutaneous manifestations of COVID-19

Acute Generalized Exanthematous Pustulosis with Erythema Multiforme-Like lesions in a COVID-19 woman.

Robustelli Test E, Vezzoli P, Carugno A, Raponi F, Gianatti A, Rongioletti F, Sena P.

Categories: Cutaneous manifestations of COVID-19

Reply to "Acute urticaria with pyrexia as the first manifestations of a COVID-19 infection": Urticaria-like lesions in COVID-19 patients are not really urticaria. A case with clinicopathologic correlation.

Rodríguez-Jiménez P, Chicharro P, De Argila D, Muñoz-Hernández P, Llamas-Velasco M.

Categories: Cutaneous manifestations of COVID-19

Histologic features of long lasting chilblain-like lesions in a pediatric COVID-19 patient.

Locatelli AG, Robustelli Test E, Vezzoli P, Carugno A, Moggio E, Consonni L, Gianatti A, Sena P.

Categories: Cutaneous manifestations of COVID-19

Chilblain acral lesions in the COVID-19 era. Are they marker of infection in asymptomatic patients?

Ramondetta A, Panzone M, Dapavo P, Ortoncelli M, Giura MT, Licciardello M, Rozzo G, Siliquini N, Fierro MT, Ribero S.

Categories: Cutaneous manifestations of COVID-19

Fever with Rash in COVID-19: Viral Exanthema or Secondary Lesions?

Goldust M, Abdelmaksoud A, Shuang Z, Xiang C, Navarini AA.

Categories: Cutaneous manifestations of COVID-19

Chilblain acral lesions in the COVID -19 era. Are they marker of infection in asymptomatic patients?

Ramondetta A, Panzone M, Dapavo P, Ortoncelli M, Giura MT, Licciardello M, Rozzo G, Siliquini N, Fierro MT, Ribero S.

Categories: Cutaneous manifestations of COVID-19

Cutaneous small vessel vasculitis secondary to COVID-19 infection: A case report

Mayor-Ibarguren A, Feito-Rodriguez M, Quintana Castanedo L, Ruiz-Bravo E, Montero Vega D, Herranz-Pinto P.

Categories: Cutaneous manifestations of COVID-19

A case of cefditoren‐induced Acute Generalized Exanthematous Pustulosis during COVID‐19 pandemics. Severe Cutaneous Adverse Reactions (SCARs) are an issue

I. Torres‐Navarro, C. Abril‐Pérez, J. Roca‐Ginés, J. Sánchez‐Arráez, R. Botella‐Estrada

Categories: Cutaneous manifestations of COVID-19

Iatrogenic dermatitis in times of COVID-19: A pandemic within a pandemic

Bhatia R, Sindhuja T, Bhatia S, Dev T, Gupta A, Bajpai M, Gupta S.

Categories: Cutaneous manifestations of COVID-19

Urticaria (angioedema) and COVID- 19 infection

Najafzadeh M, Shahzad F, Ghaderi N, Ansari K, Jacob B, Wright A.

Categories: Cutaneous manifestations of COVID-19

No antibody response in acral cutaneous manifestations associated with COVID-19 ?

Mahieu R, Tillard L, Le Guillou-Guillemette H, Vinatier E, Jeannin P, Croué A, Le Corre Y, Vandamme YM.

Categories: Cutaneous manifestations of COVID-19

Acral purpuric lesions (Erythema multiforme type) associated with thrombotic vasculopathy in a child during the COVID-19 pandemic

García-Gil MF, García García M, Monte Serrano J, Prieto-Torres L, Ara-Martín M.

Categories: Cutaneous manifestations of COVID-19

Diversity of clinical appearance of cutaneous manifestations in the course of COVID‐19

Guarneri C, Venanzi Rullo E, Gallizzi R, Ceccarelli M, Cannavò SP, Nunnari G.

Categories: Cutaneous manifestations of COVID-19

Cutaneous small-vessel vasculitis associated with novel 2019 coronavirus SARS-CoV-2 infection (COVID-19)

Dominguez-Santas M, Diaz-Guimaraens B, Garcia Abellas P, Moreno-Garcia Del Real C, Burgos-Blasco P, Suarez-Valle A.

Categories: Cutaneous manifestations of COVID-19

Late onset of acral necrosis after SARS-CoV-2 infection resolution

Balestri R, Termine S, Rech G, Girardelli CR.

Categories: Cutaneous manifestations of COVID-19

COVID-19 Presenting with Atypical Sweet’s Syndrome

Taşkın B, Vural S, Altuğ E, Demirkesen C, Kocatürk E, Çelebi İ, Ferhanoğlu B, Alper S.

Categories: Cutaneous manifestations of COVID-19

Acro-ischemia and COVID-19 infection: clinical and histopathological features

Calvão J, Relvas M, Pinho A, Brinca A, Cardoso JC.

Categories: Cutaneous manifestations of COVID-19

COVID-19: how it can look on the skin. Clinical and pathological features in twenty COVID-19 patients observed in Bologna, northeastern Italy

Gaspari V, Neri I, Misciali C, Patrizi A.

Categories: Cutaneous manifestations of COVID-19

The red half moon nail sign: a novel manifestation of Coronavirus infection

Neri I, Guglielmo A, Virdi A, Gaspari V, Starace M, Piraccini BM.

Categories: Cutaneous manifestations of COVID-19

Erythema multiforme and Kawasaki disease associated with COVID‐19 infection in children

Labé P, Ly A, Sin C, Nasser M, Chapelon-Fromont E, Ben Saïd P, Mahé E.

Categories: Cutaneous manifestations of COVID-19

Exanthema and eosinophilia in Covid-19 patients: has viral infection a role in drug induced exanthemas?

Rosell-Díaz AM, Mateos-Mayo A, Nieto-Benito LM, Balaguer-Franch I, Hernández de E, la Torre-Ruiz, Laínez-Nuez A, Suárez-Fernández R, Bergón-Sendín M.

Categories: Cutaneous manifestations of COVID-19

Cutaneous involvement during COVID-19 pandemic: an emerging sign of infection

Annunziata MC, Patrì A, Ruggiero A, Di Guida A, Menicanti C, Greco V, Fabbrocini G.

Categories: Cutaneous manifestations of COVID-19

The broad spectrum of dermatological manifestations in COVID-19. Clinical and histopathological features learned from a series of 34 cases

Rubio-Muniz CA, Puerta-Peña M, Falkenhain-López D, Arroyo-Andrés J, Agud-Dios M, Rodriguez-Peralto JL, Ortiz-Romero PL, Rivera-Díaz R.

Categories: Cutaneous manifestations of COVID-19

Histology of skin lesions establishes that the vesicular rash associated with COVID-19 is not “varicella-like”

Mahé A, Birckel E, Merklen C, Lefèbvre P, Hannedouche C, Jost M, Droy-Dupré L.

Categories: Cutaneous manifestations of COVID-19

COVID-19 AND OUTBREAK OF CHILBLAINS: ARE THEY RELATED?

Lesort C, Kanitakis J, Villani A, Ducroux E, Bouschon P, Fattouh K, Bensaid B, Danset M, Jullien D.

Categories: Cutaneous manifestations of COVID-19

Eosinophilic granulomatosis with polyangiitis mimicking COVID-19: a case report

Hashizume H, Sano Y, Furukawa S, Imokawa S.

Categories: Cutaneous manifestations of COVID-19

Retiform purpura as a dermatological sign of COVID-19 coagulopathy

Bosch-Amate X, Giavedoni P, Podlipnik S, Andreu-Febrer C, Sanz-Beltran J, Garcia-Herrera A, Alós L, Mascaró JM Jr.

Categories: Cutaneous manifestations of COVID-19

COVID-19 Lockdown induced acral dermatosis in children

Bodak N, Chiaverini C, Barbarot S.

Categories: Cutaneous manifestations of COVID-19

A clinical, histopathological and laboratory study of 19 consecutive Italian paediatric patients with chilblain-like lesions: lights and shadows on the relationship with COVID-19 infection

El Hachem M, Diociaiuti A, Concato C, Carsetti R, Carnevale C, Ciofi Degli Atti M, Giovannelli L, Latella E, Porzio O, Rossi S, Stracuzzi A, Zaffina S, Onetti Muda A, Zambruno G, Alaggio R.

Categories: Cutaneous manifestations of COVID-19

Histological findings in chilblain-lupus like COVID lesions: in search of an answer to understand their etiology.

Rodríguez-Villa Lario A, Vega-Díez D, González-Cañete M, Gómez-Zubiaur A, Pérez-Mesonero R, Bandini M, Polo-Rodríguez I, Vélez-Velázquez D, Trasobares-Marugán L.

Categories: Cutaneous manifestations of COVID-19

Major cluster of pediatric “ true ” primary chilblains during the COVID-19 pandemic:a consequence of lifestyle changes due to lockdown

Iria N, Annalucia V, Ilaria C, Alba G, Tiziana L, Liliana G, Cosimo M, Annalisa P, Marcello L.

Categories: Cutaneous manifestations of COVID-19

An unusual case of bullous hemorrhagic vasculitis in a COVID-19 patient

Negrini S, Guadagno A, Greco M, Parodi A, Burlando M.

Categories: Cutaneous manifestations of COVID-19

COVID-19 and cutaneous manifestations: A systematic review

Zhao Q, Fang X, Pang Z, Zhang B, Liu H, Zhang F.

Categories: Cutaneous manifestations of COVID-19

Cutaneous manifestations of hospitalized COVID-19 patients: A report of six cases with clinicopathologic features and viral RNA in situ hybridization

Bitar C, Chan MP, Harms PW, Fullen DR, Gudjonsson JE, Eshaq M, Renati S, Nikle AB, Allen A, Hawkins SD, Huerta T, Lowe L, Andea AA.

Categories: Cutaneous manifestations of COVID-19

Papular-Purpuric Exanthem in a COVID-19 Patient: Clinical and Dermoscopic Description

Larrondo J, Cabrera R, Gosch M, Larrondo F, Aylwin M, Castro A.

Categories: Cutaneous manifestations of COVID-19

Urticarial vasculitis in COVID-19 infection: a vasculopathy-related symptom?

de Perosanz-Lobo D, Fernandez-Nieto D, Burgos-Blasco P, Selda-Enriquez G, Carretero I, Moreno C, Fernández-Guarino M.

Categories: Cutaneous manifestations of COVID-19

A generalized purpuric eruption with histopathologic features of leucocytoclastic vasculitis in a patient severely ill with COVID-19

Caputo V, Schroeder J, Rongioletti F.

Categories: Cutaneous manifestations of COVID-19

Cutaneous autoimmune diseases during COVID 19 pandemic

Günther C, Aschoff R, Beissert S

Categories: Cutaneous manifestations of COVID-19

Relapsing symmetric livedo reticularis in a patient with COVID‐19 infection

Verheyden M, Grosber M, Gutermuth J, Velkeniers B.

Categories: Cutaneous manifestations of COVID-19

Clinical and histological characterization of late appearance maculopapular eruptions in association with the coronavirus disease 2019. A case series of seven patients.

Reymundo A, Fernáldez-Bernáldez A, Reolid A, Butrón B, Fernández-Rico P, Muñoz-Hernández P, De Argila D, Llamas-Velasco M.

Categories: Cutaneous manifestations of COVID-19

Cutaneous manifestations of SARS-CoV-2 infection: a clinical update

Gisondi P, PIaserico S, Bordin C, Alaibac M, Girolomoni G, Naldi L.

Categories: Cutaneous manifestations of COVID-19

COVID-19-related acute genital ulcers

Falkenhain-López D, Agud-Dios M, Ortiz-Romero PL, Sánchez-Velázquez A.

Categories: Cutaneous manifestations of COVID-19

SARS-CoV-2, skin lesions and the need of a multidisciplinary approach

Cabrera-Hernández R, Solano-Solares E, Chica-Guzmán V, Fernández-Guarino M, Fernández-Nieto D, Ortega-Quijano D, de-Andrés-Martín A, Moreno C, Carretero-Barrio I, García-Abellás P, González-de-Olano D, de-la-Hoz-Caballer B.

Categories: Cutaneous manifestations of COVID-19

Introductory histopathologic findings may shed light on COVID19 pediatric hyperinflammatory shock syndrome

Schnapp A, Abulhija H, Maly A, Armoni-Weiss G, Levin Y, Faitatziadou SM, Molho-Pessach V.

Categories: Cutaneous manifestations of COVID-19

Catastrophic acute bilateral lower limbs necrosis associated with COVID-19 as a likely consequence of both vasculitis and coagulopathy

Del Giudice P, Boudoumi D, Le Guen B, Reverte M, Gutnecht J, Lacour JP, Kraemer JP, Motard A, Roa M.

Categories: Cutaneous manifestations of COVID-19

Two cases of cutaneous eruptions due to COVID-19 infection in Singapore: New insights into the spectrum of clinical presentation and histopathology

Ho BWY, Wang D, Tan LYC, Bundele MM, Tan CH, Lim JH.

Categories: Cutaneous manifestations of COVID-19

Concurrent chilblains and retinal vasculitis in a child with COVID-19

Quintana-Castanedo L, Feito-Rodríguez M, Fernández-Alcalde C, Granados-Fernández M, Montero-Vega D, Mayor-Ibarguren A, de Lucas-Laguna R.

Categories: Cutaneous manifestations of COVID-19

Acute acral cutaneous manifestations during the COVID-19 pandemic: a single center experience.

García-Legaz Martínez M, Martínez-Doménech Á, Magdaleno-Tapial J, Valenzuela-Oñate C, Partarrieu-Mejías F, Lorca-Spröhnle J, Casanova-Esquembre A, Pérez-Ferriols A, Alegre-de Miquel V.

Categories: Cutaneous manifestations of COVID-19

Recent outbreak of chilblain-like lesions is not directly related with SARS-CoV-2 infection

Rouanet J, Lang E, Beltzung F, Evrard B, Henquell C, Joulie I, D'Incan M.

Categories: Cutaneous manifestations of COVID-19

Dermoscopy features of COVID-19-related chilblains in children and adolescents

Navarro L, Andina D, Noguera-Morel L, Hernández-Martín A, Colmenero I, Torrelo A.

Categories: Cutaneous manifestations of COVID-19

Cutaneous manifestations in SARS-CoV-2 infection (COVID-19): a French experience and a systematic review of the literature

Matar S, Oulès B, Sohier P, Chosidow O, Beylot-Barry M, Dupin N, Aractingi S.

Categories: Cutaneous manifestations of COVID-19

COVID-19-related cutaneous manifestations associated with multiple drug sensitization

Hayakawa J, Takakura H, Mizukawa Y, Shiohara T.

Categories: Cutaneous manifestations of COVID-19

Acral skin eruption observed during SARS-CoV-2 pandemic: red palms and soles.

Neri I, Patrizi A, Gabrielli L, Virdi A, Veronesi G, Corsini I, Lazzarotto T, Lanari M, Misciali C, Guglielmo A.

Categories: Cutaneous manifestations of COVID-19

Generalized Pustular Figurate Erythema. First Report in Two COVID-19 Patients on Hydroxychloroquine

Abadías-Granado I, Palma-Ruiz AM, Cerro PA, Morales-Callaghan AM, Gómez-Mateo MC, Gilaberte Y, Schwartz RA.

Categories: Cutaneous manifestations of COVID-19

Skin manifestations in COVID-19 provide a clue for disease’s pathophysiology understanding

Kubanov AA, Deryabin DG.

Categories: Cutaneous manifestations of COVID-19

A potential new trigger for aquagenic wrinkling of the palms caused by COVID-19 outbreak

Tai Y, Fukumoto T, Oka M, Nishigori C.

Categories: Cutaneous manifestations of COVID-19

Chilblains and COVID-19: further evidence against a causal association

M. Baeck, C. Peeters, A. Herman

Categories: Cutaneous manifestations of COVID-19

Cutaneous Symptoms of Patients Diagnosed with Covid-19 in One Province: A Cross-Sectional Survey

Öksüm Solak E, Baran Ketencioglu B, Aslaner H, Çinar SL, Kartal D, Benli AR, Borlu M.

Categories: Cutaneous manifestations of COVID-19

Self-reported cutaneous manifestations in 1,429 Brazilian COVID-19 patients

Miot HA, Ianhez M, Ramos PM.

Categories: Cutaneous manifestations of COVID-19

Why are chilblains underreported in Nordic countries during the COVID-19 pandemic? An analysis of Google trends

Kluger N.

Categories: Cutaneous manifestations of COVID-19

SARS-CoV-2-induced telogen effluvium: a multicentric study

O.M. Moreno‐Arrones A. Lobato‐Berezo A. Gomez‐Zubiaur S. Arias‐Santiago D. Saceda‐Corralo C. Bernardez‐Guerra R. Grimalt P. Fernandez‐Crehuet J. Ferrando R. Gil A. Hermosa‐Gelbard R. Rodrigues‐Barata D. Fernandez‐Nieto S. Merlos‐Navarro S. Vañó‐Galván

Categories: Cutaneous manifestations of COVID-19

Lack of skin manifestations in COVID-19 hospitalized patients during the second epidemic wave in Spain: a possible association with a novel SARS-CoV-2 variant. A cross-sectional study

D. Fernandez‐Nieto D. Ortega‐Quijano A. Suarez‐Valle J. Jimenez‐Cauhe P. Jaen‐Olasolo M. Fernandez‐Guarino

Categories: Cutaneous manifestations of COVID-19

Palmoplantar erythrodysesthesia: a diagnostic sign of COVID‐19

A. Nuno‐Gonzalez K. Magaletsky M. Feito Rodríguez A. Mayor Ibarguren M.J. Beato E. Ruiz Bravo P. Herranz Pinto

Categories: Cutaneous manifestations of COVID-19

Pityriasis rosea as a leading manifestation of COVID-19 infection

R. Merhy A.S. Sarkis F. Stephan

Categories: Cutaneous manifestations of COVID-19

Absence of SARS-CoV-2 RNA detection in tissue samples of COVID-19-related cutaneous lesions analyzed by real-time RT-PCR

M. F. García‐Gil J. Monte‐Serrano M. García García L. Prieto‐Torres A. J. Pascual‐del‐Riquelme I. Casas Flecha M. Ara‐Martín

Categories: Cutaneous manifestations of COVID-19

Chilblain-like lesions and COVID-19: second wave, second outbreak

V. Piccolo A. Bassi T. Russo C. Mazzatenta M. Baraldi G. Argenziano I. Neri M. Cutrone

Categories: Cutaneous manifestations of COVID-19

Relapse of chilblain-like lesions during the second wave of COVID-19

S. Recalcati T. Barbagallo S. Tonolo M. Milani F. Fantini

Categories: Cutaneous manifestations of COVID-19

Chilblains in a child with confirmed SARS-CoV-2 infection: a red flag for late onset skin manifestation in previously infected individuals

I. Neri F. Conti A. Virdi A. Guglielmo L. Leonardi I. Corsini C. Ghizzi L. Gabrielli T. Lazzarotto M. Lanari A. Patrizi C. Misciali

Categories: Cutaneous manifestations of COVID-19

Association Between COVID-19 and Chilblains: A Case-Control Study

D. Ortega‐Quijano D. Fernandez‐Nieto J. Jimenez‐Cauhe J.L. Cortes‐Cuevas D. Marcos‐Mencia M. Rodriguez‐Dominguez G. Segurado‐Miravalles M. Fernandez‐Guarino P. Jaen‐Olasolo

Categories: Cutaneous manifestations of COVID-19

Follow-up of dermatological manifestations in non-critical hospitalized patients with COVID-19 pneumonia and their prognostic correlation with disease severity

A. García‐Irigoyen G.A. Acatitla‐Acevedo A. Barrera‐Godínez S. Méndez‐Flores J. Domínguez‐Cherit

Categories: Cutaneous manifestations of COVID-19

Periocular capillaritis in a COVID-19 positive patient: report of a case

A. Paganelli F. Garbarino L. Bigi

Categories: Cutaneous manifestations of COVID-19

Under-representation of people of African ancestry in publications on the cutaneous manifestations of COVID-19: coincidence or physiology?

C Cassius L Frumholtz A de Masson O Dadzie A Petit Saint‐Louis CORE (COvid Research) group

Categories: Cutaneous manifestations of COVID-19

Recurrence of previous chilblain lesions during the second wave of COVID-19: can we still doubt the correlation with SARS-CoV-2?

S Signa AR Sementa MC Coccia C Pastorino G Viglizzo S Viola S Volpi C Occella D Bleidl M Acquila E Castagnola A Ravelli F Manunza

Categories: Cutaneous manifestations of COVID-19

Covid-19-triggered sarcoidal granulomas mimicking scar sarcoidosis

A Polat Ekinci N Büyükbabani S Meşe G Pehlivan NG Okumuş A Ağaçfidan E Özkaya

Categories: Cutaneous manifestations of COVID-19

Acute postinfectious Pityriasis Rubra Pilaris as a cutaneous manifestation in COVID-19: a case report and its dermoscopic features

D. Kadylak, W. Barańska-Rybak

Categories: Cutaneous manifestations of COVID-19

Non-acral skin manifestations during the COVID-19 epidemic: COVIDSKIN study by the French Society of Dermatology

R. Guelimi, R. Salle, L. Dousset, H. Assier, S. Fourati, Z. Bhujoo, S. Barbarot, C. Boulard, C. Cazanave, A. Colin, E. Kostrzewa, C. Lesort, A. Levy Roy, F. Lombart, J. Marco Bonnet, L. Marty, J.B. Monfort, L. Riffaud, M. Samimi, M. Tardieu, E. Sbidian, P. Wolkenstein, L. Le Cleach, M. Beylot-Barry

Categories: Cutaneous manifestations of COVID-19

Heterogeneous red-white discoloration of the nail bed and distal onycholysis in a patient with COVID-19

Betul Demir, Esma Inan Yuksel, Demet Cicek, Sedatcan Turkoglu

Categories: Cutaneous manifestations of COVID-19

Recurrent injection-site reactions after incorrect subcutaneous administration of the BNT162b2 vaccine against SARS-CoV-2

M. Gyldenløve, L. Skov, C.B. Hansen, P. Garred

Categories: Cutaneous manifestations of COVID-19

Frequency of relapse and persistent cutaneous symptoms after a first episode of chilblain-like lesion during the COVID-19 pandemic

Parna Moghadam, Laure Frumholtz, Léa Jaume, Adèle De Masson, Marie Jachiet, Edouard Begon, Luc Sulimovic, Antoine Petit, Hervé Bachelez, Martine Bagot, Jean-David Bouaziz, Charles Cassius, Saint-Louis CORE (COvid REsearch)

Categories: Cutaneous manifestations of COVID-19

Urticarial Vasculitis revealing immunolabelled nucleocapsid protein of SARS-CoV-2 in two Brazilian asymptomatic patients: the tip of the COVID-19 hidden iceberg?

Paulo Ricardo Criado, Roberta Fachini Jardim Criado, Raffaele Gianotti, Beatrice Artinez Zugaib Abdalla, Thais Prota Hussein Pincelli, Alexandre Osores Michalany, Nilceo Schwery Michalany

Categories: Biologics and immunomodulatory therapies

Should SARS-CoV-2 influence immunosuppressive therapy for autoimmune blistering diseases?

Di Altobrando A, Patrizi A, Bardazzi F.

Categories: Biologics and immunomodulatory therapies

SARS-CoV-2 infection in a psoriatic patient treated with IL-23 inhibitor.

Messina F, Piaserico S.

Categories: Biologics and immunomodulatory therapies

Safety of dupilumab in severe atopic dermatitis and infection of Covid-19: two case reports.

Ferrucci S, Romagnuolo M, Angileri L, Berti E, Tavecchio S.

Categories: Biologics and immunomodulatory therapies

No evidence of increased risk for COVID-19 infection in patients treated with Dupilumab for atopic dermatitis in a high-epidemic area - Bergamo, Lombardy, Italy.

Carugno A, Raponi F, Locatelli AG, Vezzoli P, Gambini DM, Di Mercurio M, Robustelli Test E, Sena P.

Categories: Biologics and immunomodulatory therapies

"Toxic Erythema" and Eosinophilia Associated to Tocilizumab Therapy in a COVID-19 Patient

Sernicola A, Carnicelli G, Di Fraia M, Chello C, Furlan C, Muharremi R, Paolino G, Grieco T.

Categories: Biologics and immunomodulatory therapies

Evolution of COVID-19 infection in 4 psoriatic patients treated with biological drugs.

Conti A, Lasagni C, Bigi L, Pellacani G.

Categories: Biologics and immunomodulatory therapies

Improvement of SARS-CoV2 symptoms following guselkumab injection in a psoriatic patient.

Benhadou F, Del Marmol V.

Categories: Biologics and immunomodulatory therapies

SARS-CoV-2 asymptomatic infection in a patient under treatment with dupilumab.

Caroppo F, Biolo G, Belloni Fortina A.

Categories: Biologics and immunomodulatory therapies

SARS-CoV-2 infection in a psoriatic patient treated with IL-17 inhibitor.

Balestri R, Rech G, Girardelli CR.

Categories: Biologics and immunomodulatory therapies

Prior treatment with immunosuppressants among COVID-19 inpatients in one hospital in Spain

Pastor-Nieto MA, Checa-Díaz P, González-Muñoz P, Martín-Fuentes A, Vergara-Sánchez A, Sánchez-Herreros C, Jiménez-Blázquez E, Cabana-Navia R, Martínez-Mariscal J, Cobo-Rodríguez P, Checa-Recio I, Gatica-Ortega ME, Torralba M, De Eusebio-Murillo E.

Categories: Biologics and immunomodulatory therapies

Systemic or biologic treatment in psoriasis patients does not increase the risk of a severe form of COVID-19

Fougerousse AC, Perrussel M, Bécherel PA, Begon E, Pallure V, Zaraa I, Chaby G, Parier J, Kemula M, Mery-Bossard L, Poreaux C, Taieb C, Maccari F, Reguiai Z; GEM Resopso.

Categories: Biologics and immunomodulatory therapies

Compliance, safety concerns and anxiety in patients treated with biologics for psoriasis during the COVID-19 pandemic national lockdown: A multicenter study in the Czech Republic

Rob F, Hugo J, Tivadar S, Boháč P, Gkalpakiotis S, Vargová N, Arenbergerová M, Hercogová J.

Categories: Biologics and immunomodulatory therapies

Toxic epidermal necrolysis and co-existent SARS-CoV-2 (COVID-19) treated with Intravenous Immunoglobulin: "Killing 2 birds with one stone ”

Saha M, D'Cruz A, Paul N, Healy R, Collins D, Charles DA, Sahu S, Fonia A.

Categories: Biologics and immunomodulatory therapies

Position Statement for a Pragmatic Approach to Immunotherapeutics in Patients with Inflammatory Skin Diseases during the COVID-19 Pandemic and Beyond

J. Beecker K.A. Papp J. Dutz R.B. Vender R. Gniadecki C. Cooper P. Gisondi M. Gooderham C.H. Hong M.G. Kirchhof C.W. Lynde C. Maari Y. Poulin L. Puig

Categories: Biologics and immunomodulatory therapies

Understanding Views of Patients on Biologics for Psoriasis Amid the COVID-19 Pandemic

K. Pandher C.L. Porter H.S. Patel W.W. Huang S.R. Feldman

Categories: Biologics and immunomodulatory therapies

Good tolerance of hyaluronic acid injections during the Covid-19 pandemic period: a prospective observational real-life study of a cohort of 1093 patients with a 3 month-follow up period

Michael Naouri Serge Dahan Anne Le Pillouer Prost Phrynée Coutant‐Foulc Catherine Raimbault Françoise Cucurella Laurence Beille Muriel Creusot Martine Baspeyras Martine Darchy Randa Khallouf Hugues Cartier Isabelle Baratte Magali Dubois Olivier Cogrel Hans Laubach Groupe de Dermatologie Esthétique et Correctrice de la Société Française de Dermatologie (GDEC)

Categories: Biologics and immunomodulatory therapies

Autoantibodies in Covid19 – A model for viral induced autoimmunity

J. Berger, S. Volc

Categories: Clinical set-up and service delivery

What dermatologists could do to cope with the novel coronavirus (SARS-CoV-2): a dermatologist's perspective from China.

Zhang H, Tang K, Fang R, Sun Q.

Categories: Clinical set-up and service delivery

Global coronavirus pandemic (2019-nCOV): Implication for an Italian medium size dermatological clinic of a ii level hospital.

Radi G, Diotallevi F, Campanati A, Offidani A.

Categories: Clinical set-up and service delivery

Art of performing dermoscopy during the times of coronavirus disease (COVID-19): Simple change in approach can save the day!

Jakhar D, Kaur I, Kaul S.

Categories: Clinical set-up and service delivery

Face the COVID-19 emergency: measures applied in an Italian dermatologic clinic.

Marasca C, Ruggiero A, Annunziata MC, Fabbrocini G, Megna M.

Categories: Clinical set-up and service delivery

Dermatologists and SARS-CoV-2: The impact of the pandemic on daily practice.

Gisondi P, Piaserico S, Conti A, Naldi L.

Categories: Clinical set-up and service delivery

Changes in emergency service access after spread of COVID19 across Italy

Tartari F, Guglielmo A, Fuligni F, Pileri A.

Categories: Clinical set-up and service delivery

COVID-19 and dermatology: A comprehensive guide for dermatologists.

Fahmy DH, El-Amawy HS, El-Samongy MA, Foud AA, Soliman SH, El-Kady A, Farnetani F, Conti A, Zoeir A, Eissa A, Eissa R, Puliatti S, Sighinolfi MC, Rocco B, Pellacani G.

Categories: Clinical set-up and service delivery

Active implications for dermatologists in "SARS-CoV-2 era": Personal experience and review of literature.

Campanati A, Brisigotti V, Diotallevi F, D'Agostino GM, Paolinelli M, Radi G, Rizzetto G, Sapigni C, Tagliati C, Offidani A.

Categories: Clinical set-up and service delivery

Teledermatology for COVID-19 cutaneous lesions: substitute or supplement?

Skayem C, Cassius C, Ben Kahla M, Fiani C, Frumholtz L, Mrad M, Petit A, Zuelgaray E, Bagot M, Bouaziz JD, Duong TA.

Categories: Clinical set-up and service delivery

The COVID-19 outbreak in dermatologic surgery: resetting clinical priorities

E. Rossi, M. Trakatelli, L. Giacomelli, B. Ferrari, M. Francomano, G. Pellacani, C. Magnoni

Categories: Clinical set-up and service delivery

Teledermatology for acne during COVID-19: high patients’ satisfaction nevertheless the emergency

Ruggiero A, Megna M, Annunziata MC, Abategiovanni L, Scalvenzi M, Tajani A, Fabbrocini G, Villani A.

Categories: Clinical set-up and service delivery

A SURVEY ON TELEDERMATOLOGY (TD) USE AND DOCTORS’ PERCEPTION IN TIMES OF COVID-19

Moscarella E, Pasquali P, Cinotti E, Tognetti L, Argenziano G, Rubegni P.

Categories: Clinical set-up and service delivery

Management of biological therapies for chronic plaque psoriasis during COVID-19 emergency in Italy

Talamonti M, Galluzzo M, Chiricozzi A, Quaglino P, Fabbrocini G, Gisondi P, Marzano AV, Potenza C, Conti A, Parodi A, Belloni Fortina A, Bardazzi F, Argenziano G, Rongioletti F, Stingeni L, Micali G, Loconsole F, Venturini M, Bongiorno MR, Feliciani C, Rubegni P, Amerio P, Fargnoli MC, Pigatto P, Savoia P, Nisticò SP, Giustini S, Carugno A, Cannavò SP, Rech G, Prignano F, Offidani A, Lombardo M, Zalaudek I, Bianchi L, Peris K; PSO-BIO-COVID study group.

Categories: Clinical set-up and service delivery

RECOMMENDATIONS FOR SKIN CANCER CONSULTATION AND SURGERY DURING COVID-19 PANDEMIC

Brochez, L., Baurain, J.F., Del Marmol, V., Nikkels, A., Kruse, V., Sales, F., Stas, M., Van Laethem, A, Garmyn, M.

Categories: Clinical set-up and service delivery

Comment on “Drug reaction with eosinophilia and systemic symptoms syndrome in a patient with COVID-19”: Involvement of herpesvirus reactivations and adverse drug reactions in diverse cutaneous manifestations and overall disease severity of COVID-19

Shiohara T, Mizukawa Y

Categories: Clinical set-up and service delivery

Impact of the COVID-19 Pandemic on Inpatient Dermatology: A Multicenter Study from Hubei, China

Y. Zhang J. Wen M. Alamgir J. Xie H. Jing M. Fang J. Wang M. Zhang Z. Meng L. Yang J. Tao

Categories: Clinical set-up and service delivery

An Irish Department of Genito-Urinary Medicine in the COVID-19 Era

D. Moriarty C. O'Connor J. Bourke M. Murphy M. Horgan S. Cremin

Categories: Coronavirus aetiology, severity and transmission

5-Alpha-Reductase Inhibitors are Associated with Reduced Frequency of COVID-19 Symptoms in Males with Androgenetic Alopecia

J. McCoy F.A. Cadegiani C.G. Wambier S. Herrera S. Vaño‐Galván N.A. Mesinkovska P.M. Ramos J. Shapiro R. Sinclair A. Tosti A. Goren

Categories: Coronavirus aetiology, severity and transmission

Extraordinary claims without extraordinary evidence Controversy on Anti-Androgen Therapy for COVID-19

R.M. Trüeb A. Régnier N. Caballero‐Uribe M.F. Reis Gavazzoni Dias H. Dutra Rezende

Categories: Coronavirus drugs

Prompt onset of erythema multiforme following the first BNT162b2 SARS-CoV-2 vaccination

T. Gambichler L. Scholl L. Ocker R. Stranzenbach

Categories: Coronavirus drugs

Lichen planus arising after COVID-19 vaccination

I. Hiltun J. Sarriugarte I. Martínez‐de‐Espronceda A. Garcés C. Llanos R. Vives J.I. Yanguas

Categories: Coronavirus drugs

Persistent maculopapular rash after the first dose of Pfizer-BioNTech COVID-19 vaccine

M. Ackerman D. Henry A. Finon R. Binois E. Esteve

Categories: Coronavirus drugs

Skin manifestations of the BNT162b2 mRNA COVID-19 vaccine in healthcare workers. “COVID-arm”: a clinical and histological characterization

D. Fernandez‐Nieto J. Hammerle M. Fernandez‐Escribano CM Moreno‐del Real P. Garcia‐Abellas I. Carretero‐Barrio E. Solano‐Solares B de‐la‐Hoz‐Caballer J. Jimenez‐Cauhe D. Ortega‐Quijano M. Fernandez‐Guarino

Categories: Coronavirus drugs

Pityriasis rosea following CoronaVac COVID-19 vaccination: a case report

E. Akdaş N. İlter B. Öğüt Ö. Erdem

Categories: Coronavirus drugs

BNT162b2 mRNA Covid-19 Vaccine-induced chilblain-like lesions reinforces the hypothesis of their relationship with SARS-CoV-2

V. Piccolo, A. Bassi, G. Argenziano, C. Mazzatenta, M. Cutrone, I. Neri, R. Grimalt, T. Russo

Categories: Coronavirus drugs

Anaphylaxis to vaccination and polyethylene glycol (PEG): A perspective from the European Anaphylaxis Registry

M Kraft, JM Renaudin, LF Ensina, A Kleinheinz, MB Bilò, K Scherer Hofmeier, S Dölle-Bierke, M Worm

Categories: Coronavirus drugs

Cutaneous adverse reactions after m-RNA COVID-19 vaccine: early reports from North-East Italy

E. Farinazzo, G. Ponis, E. Zelin, E. Errichetti, G. Stinco, C. Pinzani, A. Gambelli, N. De Manzini, L. Toffoli, A. Moret, M. Agozzino, C. Conforti, N. Di Meo, P. Schincariol, I. Zalaudek

Categories: Coronavirus drugs

Pityriasis rosea-like eruptions following vaccination with BNT162b2 mRNA COVID-19 Vaccine

Benoit Cyrenne, Faisal Al-Mohammedi, Joel DeKoven, Raed Alhusayen

Categories: Coronavirus drugs

Purpuric lesions on the eyelids developed after BNT162b2 mRNA Covid-19 Vaccine: another piece of SARS-CoV-2 skin puzzle?

C. Mazzatenta, V. Piccolo, G. Pace, I. Romano, G. Argenziano, A. Bassi

Categories: Coronavirus drugs

Ipsilateral Herpes Zoster after the first dose of BNT162b2 mRNA COVID-19 vaccine

I. Tessas, N. Kluger

Categories: Coronavirus drugs

SARS-CoV-2 mRNA Vaccine-Associated Fixed Drug Eruption

Dillon Mintoff, David Pisani, Alexandra Betts, Lawrence Scerri

Categories: Ocupational skin disease, including effects of PPE

Dermatology staff participate in fight against Covid-19 in China.

Zheng Y, Lai W.

Categories: Ocupational skin disease, including effects of PPE

Skin reactions to non-glove personal protective equipment: An emerging issue in the COVID-19 pandemic.

Gheisari M, Araghi F, Moravvej H, Tabary M, Dadkhahfar S.

Categories: Ocupational skin disease, including effects of PPE

Covid-19: Countermeasure for N95 mask-induced pressure sore.

Yin Z.

Categories: Ocupational skin disease, including effects of PPE

Hand disinfection in the combat against Covid-19.

Goldust M, Abdelmaksoud A, Navarini AA.

Categories: Ocupational skin disease, including effects of PPE

COVID-19 epidemic: Skin protection for health care workers must not be ignored.

Zhang B, Zhai R, Ma L.

Categories: Ocupational skin disease, including effects of PPE

Occupational skin conditions on the frontline: A survey among 484 Chinese healthcare professionals caring for Covid-19 patients.

Pei S, Xue Y, Zhao S, Alexander N, Mohamad G, Chen X, Yin M.

Categories: Ocupational skin disease, including effects of PPE

Localised mid-face miliaria as a consequence of filtering face piece (FFP) respirator use during the COVID-19 pandemic.

Campbell V, Middleton D, Donnelly J, Hunter H.

Categories: Ocupational skin disease, including effects of PPE

Personal protective equipment induced facial dermatoses in healthcare workers managing COVID-19 cases.

Singh M, Pawar M, Bothra A, Maheshwari A, Dubey V, Tiwari A, Kelati A.

Categories: Ocupational skin disease, including effects of PPE

Efficacy of hydrogel patches in preventing facial skin damage caused by mask compression in fighting against coronavirus disease-2019: a short-term, self-controlled study.

Dong L, Yang L, Li Y, Yang J, An X, Yang L, Zhou N, Zhang Y, Du H, Lan J, Song Z, Miao X, Zhu J, Tao J.

Categories: Occupational and nosocomial skin disease, including effects of PPE

Protecting medical staff from skin injury/disease caused by personal protective equipments during epidemic period of COVID-19: experience from China

H. Long, H. Zhao, Z. Yao, B. Cheng, Q. Lu

Categories: Occupational and nosocomial skin disease, including effects of PPE

Hand Eczema Pandemic Caused by COVID-19 Hygiene Measures: The Setup of a Hand Eczema Helpline for Hospital Personnel

K. Greveling, A.C.M. Kunkeler

Categories: Occupational and nosocomial skin disease, including effects of PPE

Retroauricular dermatitis with vehement use of ear loop face masks during COVID‐19 pandemic

Bothra A, Das S, Singh M, Pawar M, Maheswari A.

Categories: Occupational and nosocomial skin disease, including effects of PPE

Occupational skin disease during the COVID-19 pandemic, as captured in a Dermatology staff clinic in the United Kingdom

Hadjieconomou S, Hughes J, Kamath S.

Categories: Occupational and nosocomial skin disease, including effects of PPE

Symmetric chest pressure ulcers, consequence of prone position ventilation in a patient with COVID-19.

Martínez Campayo N, Bugallo Sanz JI, Mosquera Fajardo I.

Categories: Occupational and nosocomial skin disease, including effects of PPE

How the use of surgical masks during COVID-19 pandemic can induce skin effects

Veronese S, Bernardi P, Sbarbati A.

Categories: Occupational and nosocomial skin disease, including effects of PPE

Occupational dermatoses from PPE during the COVID-19 pandemic in the tropics – A review.

Lee HC, Goh CL.

Categories: Occupational and nosocomial skin disease, including effects of PPE

Adverse skin reactions following different types of mask usage during the COVID-19 pandemic

C. Chaiyabutr T. Sukakul C. Pruksaeakanan J. Thumrongtharadol W. Boonchai

Categories: Occupational and nosocomial skin disease, including effects of PPE

ADVERSE SKIN REACTIONS RELATED TO PPE AMONG HEALTH CARE WORKERS MANAGING COVID-19

Priyanka Sharma Nainika Goel Kanika Dogar Mala Bhalla GP Thami Kavita Punia

Categories: Education

Medical education and care in dermatology during the SARS-CoV2 pandemia: challenges and chances.

Reinholz M, French LE.

Categories: Education

Dermatologic Surgery Training During the COVID-19 Era

García-Lozano JA, Cuellar-Barboza A, Garza-Rodríguez V, Vázquez-Martínez O, Ocampo-Candiani J.

Categories: Psycho-social implications

Mass quarantine measures in the time of COVID-19 pandemic: psycho-social implications for chronic skin conditions and a call for qualitative studies.

Garcovich S, Bersani FS, Chiricozzi A, De Simone C.

Categories: Sexual health

SARS-CoV-2 possible contamination of genital area: implications for sexual and vertical transmission routes.

Delfino M, Guida M, Patrì A, Spirito L, Gallo L, Fabbrocini G.

Categories: Sexual health

Sexually Transmitted Infections during the COVID-19 outbreak: comparison of patients referring to the service of sexually transmitted diseases during the sanitary emergency with those referring during the common practice

Sacchelli L, Viviani F, Orioni G, Rucci P, Rosa S, Lanzoni A, Patrizi A, Gaspari V.

Categories: Sexual health

STIs and the COVID-19 pandemic: the lockdown does not stop sexual infections

Balestri R, Magnano M, Rizzoli L, Infusino SD, Urbani F, Rech G.

Categories: Specific diseases and patient groups

European Task Force on Atopic Dermatitis (ETFAD) statement on severe acute respiratory syndrome coronavirus 2 (SARS‐Cov‐2)‐infection and atopic dermatitis.

Wollenberg A, Flohr C, Simon D, Cork MJ, Thyssen JP, Bieber T, de Bruin-Weller MS, Weidinger S, Deleuran M, Taieb A, Paul C, Trzeciak M, Werfel T, Seneschal J, Barbarot S, Darsow U, Torrelo A, Stalder JF, Svensson Å, Hijnen D, Gelmetti C, Szalai Z, Gieler U, De Raeve L, Kunz B, Spuls P, von Kobyletzki LB, Fölster-Holst R, Chernyshov PV, Cristen-Zaech S, Heratizadeh A, Ring J, Vestergaard C

Categories: Specific diseases and patient groups

Expert recommendations for the management of autoimmune bullous diseases during the COVID-19 pandemic.

Kasperkiewicz M, Schmidt E, Fairley JA, Joly P, Payne AS, Yale ML, Zillikens D, Woodley DT.

Categories: Specific diseases and patient groups

Skin cancer triage and management during COVID-19 pandemic.

Tagliaferri L, Di Stefani A, Schinzari G, Fionda B, Rossi E, Del Regno L, Gentileschi S, Federico F, Valentini V, Tortora G, Peris K; Gemelli Skin-Cancer Multidisciplianry Tumour Board (S-MDTB).

Categories: Specific diseases and patient groups

Psoriasis health care in the time of the coronavirus pandemic: insights from dedicated centers in Sardinia (Italy).

Atzori L, Mugheddu C, Addis G, Sanna S, Satta R, Ferreli C, Atzori MG, Montesu MA, Rongioletti F.

Categories: Specific diseases and patient groups

Estimated effect of COVID-19 lockdown on melanoma thickness and prognosis: a rate of growth model.

Tejera-Vaquerizo A, Nagore E.

Categories: Specific diseases and patient groups

Metastatic melanoma treatment with check point inhibitors in the COVID-19 era: experience from an Italian Skin Cancer Unit.

Quaglino P, Fava P, Brizio M, Marra E, Rubatto M, Agostini A, Tonella L, Ribero S, Fierro MT.

Categories: Specific diseases and patient groups

European Task Force on Contact Dermatitis statement on coronavirus 19 disease (COVID-19) outbreak and the risk of adverse cutaneous reactions.

Balato A, Ayala F, Bruze M, Crepy MN, Gonçalo M, Duus Johansen J, John SM, Pigatto P, Raimondo A, Rustemeyer T, Schuttelaar MA, Svedman C, Aerst O, Uter W, Wilkinson M, Gimenez-Arnau A.

Categories: Specific diseases and patient groups

Management of primary cutaneous lymphoma patients during COVID-19 pandemic: EORTC CLTF guidelines.

Papadavid E, Scaribrick J, Ortiz Romero P, Guaglino P, Vermeer M, Knobler R, Stadler R, Bagot M.

Categories: Specific diseases and patient groups

Occurrence of SARS-CoV-2 during mycophenolate mofetil treatment for pemphigus.

Balestri R, Rech G, Girardelli CR.

Categories: Specific diseases and patient groups

COVID-19 pulmonary infection in erythrodermic psoriatic patient with oligodendroglioma: safety and compatibility of apremilast with critical intensive care management.

Mugheddu C, Pizzatti L, Sanna S, Atzori L, Rongioletti F.

Categories: Specific diseases and patient groups

COVID-19 pulmonary infection in erythrodermic psoriatic patient with oligodendroglioma: safety and compatibility of apremilast with critical intensive care management.

Mugheddu C, Pizzatti L, Sanna S, Atzori L, Rongioletti F.

Categories: Specific diseases and patient groups

Treatment adherence in psoriatic patients during COVID-19 pandemic: Real-world data from a tertiary hospital in Greece

Vakirlis AE, Bakirtzi K, Papadimitriou I, Vrani F, Sideris N, Lallas A, Ioannides D, Sotiriou E.

Categories: Specific diseases and patient groups

Drug reaction with eosinophilia and systemic symptoms syndrome in a patient with COVID-19

Herman A, Matthews M, Mairlot M, Nobile L, Fameree L, Jacquet LM, Baeck M.

Categories: Specific diseases and patient groups

Severe COVID-19 outcomes in patients with psoriasis

Lima XT, Cueva MA, Lopes EM, Alora MB.

Categories: Specific diseases and patient groups

Scabies outbreak during home confinement due to the SARS-CoV-2 pandemic

Martínez-Pallás I, Aldea-Manrique B, Ramírez-Lluch M, Vinuesa-Hernando JM, Ara-Martín M.

Categories: Specific diseases and patient groups

Concerns related to the COVID-19 pandemic in adult patients with atopic dermatitis and psoriasis treated with systemic immunomodulatory therapy: a Danish questionnaire survey

Dyrberg Loft N, Halling AS, Iversen L, Vestergaard C, Deleuran M, Rasmussen MK, Zachariae C, Thyssen JP, Skov L.

Categories: Specific diseases and patient groups

DELAYED MELANOMA DIAGNOSIS IN THE COVID-19 ERA: INCREASED BRESLOW THICKNESS IN PRIMARY MELANOMAS SEEN AFTER THE COVID-19 LOCKDOWN

Ricci F, Fania L, Paradisi A, Di Lella G, Pallotta S, Sobrino L, Panebianco A, Annessi G, Abeni D.

Categories: Specific diseases and patient groups

Clinical Characteristics and Outcomes in Patients With COVID-2019 and Leprosy

Santos VS, Quintans-Júnior LJ, de Souza Barboza W, Antunes de Souza Araújo A, Ricardo Martins-Filho P.

Categories: Specific diseases and patient groups

Wearing a mask and facial skin diseases: patients with atopic dermatitis express themselves

Stéphanie Merhand, Laurent Misery, Véronique Delvigne, Caroline Le Floch, Charles Taïeb

Categories: Specific diseases and patient groups

Scabies outbreak during home confinement due to the SARS-CoV-2 pandemic

Martínez-Pallás I, Aldea-Manrique B, Ramírez-Lluch M, Vinuesa-Hernando JM, Ara-Martín M.

Categories: Specific diseases and patient groups

Effects of lockdown on health of patients with severe atopic dermatitis treated with dupilumab

Ferrucci SM, Tavecchio S, Favale EM, Angileri L, Riva D, Romagnuolo M, Beretta AE, Marzano AV.

Categories: Specific diseases and patient groups

Comment on “Drug reaction with eosinophilia and systemic symptoms syndrome in a patient with COVID-19”: Involvement of herpesvirus reactivations and adverse drug reactions in diverse cutaneous manifestations and overall disease severity of COVID-19

Categories: Specific diseases and patient groups

Immunological and virological profile of children with chilblain-like lesions shows no evident link with SARS-CoV-2

L. Fertitta, A. Welfringer, A. Ouedrani, L. Polivka, S. Chhun, L. Chatenoud, J. Fourgeaud, S. Hadj‐Rabia, S. Temmam, M. Eloit, Sermet‐Gaudelus, C. Bodemer

Categories: Specific diseases and patient groups

Diagnosis of hair disorders during the COVID-19 pandemic: An introduction to teletrichoscopy.

Categories: Specific diseases and patient groups

Diagnosis of hair disorders during the COVID-19 pandemic: An introduction to teletrichoscopy.

Randolph, M, Al‐alola A, Tosti A

Categories: Specific diseases and patient groups

COVID-19 in patients with cutaneous immune-mediated diseases in The Netherlands: real-world observational data

L.E.M. de Wijs M.M. Joustra J.I. Olydam T. Nijsten D.J. Hijnen

Categories: Specific diseases and patient groups

COVID-19 and HHV8 first spotted together: an affair under electron microscopy

E. Leoni M. Cerati G. Finzi M. Lombardo F. Sessa

Categories: Specific diseases and patient groups

Concerns and perceptions of patients with psoriatic disease during the COVID-19 pandemic: results from a two-wave survey by the National Psoriasis Foundation

G.C. Gondo S.J. Bell J. Slayden G. Ullmann A. Blauvelt

Categories: Specific diseases and patient groups

Is SARS-CoV-2 screening test indicated for psoriasis patients candidate to biologic therapy?

S. Piaserico P. Gisondi S. Cazzaniga G. Girolomoni P.G. Calzavara‐Pinton L. Naldi

Categories: Specific diseases and patient groups

COVID-19 and immune checkpoint inhibitors

M.S. Ahmed H. Brehme S. Friedrich L. Reinhardt S. Blum S. Beissert F. Meier

Categories: Specific diseases and patient groups

RAPIDLY PROGRESSIVE ALOPECIA AREATA TOTALIS IN A COVID-19 PATIENT, UNRESPONSIVE TO TOFACITINIB

S. Berbert Ferreira M.F.R. Gavazzoni Dias R. Berbert Ferreira A.C. Neves Neto R.M. Trüeb O. Lupi

Categories: Specific diseases and patient groups

Insights into COVID-19 vaccination in patients with chronic plaque psoriasis on systemic treatments

P. Gisondi D. Geat L. Naldi S. Piaserico

Categories: Specific diseases and patient groups

COVID-19 pandemic and autoimmune bullous diseases: A cross-sectional study of the International Pemphigus and Pemphigoid Foundation

M. Kasperkiewicz M. Yale R. Strong D. Zillikens D.T. Woodley A. Recke

Categories: Specific diseases and patient groups

Risk of severe allergic reactions to Covid-19 vaccines among patients with allergic or inflammatory skin diseases – practical recommendations. A position statement of ETFAD with external experts

J. Ring M. Worm A. Wollenberg J.P. Thyssen T. Jakob L. Klimek C. Bangert S. Barbarot T. Bieber M.S. de Bruin‐Weller P.V. Chernyshov S. Christen‐Zaech M. Cork U. Darsow C. Flohr R. Fölster‐Holst C. Gelmetti U. Gieler J. Gutermuth A. Heratizadeh D.J. Hijnen L.B. von Kobyletzki B. Kunz C. Paul L. De Raeve J. Seneschal D. Simon P.I. Spuls J.F. Stalder A. Svensson Z. Szalai A. Taieb A. Torrelo M. Trzeciak C. Vestergaard T. Werfel S. Weidinger M. Deleuran

Categories: Specific diseases and patient groups

VACCINATION AGAINST SARS-COV-2 and PSORIASIS: the three things every dermatologist should know

F. Diotallevi A. Campanati G. Radi E. Martina G. Rizzetto P Barbadoro M.M. D’Errico A. Offidani

Categories: Specific diseases and patient groups

Incidence and prognosis of COVID-19 in psoriasis patients on biologic therapy: a multicenter retrospective cohort study

Jorge R. Georgakopoulos Asfandyar Mufti Ron Vender Vimal H. Prajapati Jensen Yeung

Categories: Specific diseases and patient groups

Penile ischemia secondary to COVID-19: Why should the dermatologist be concerned?

P. Sarkis J. Sarkis M. Alkassis J. Assaf K. El Gharib

Categories: Specific diseases and patient groups

Pityriasis rosea, COVID-19 and vaccination: new keys to understand an old acquaintance

JM Busto‐Leis G Servera‐Negre A Mayor‐Ibarguren E Sendagorta‐Cudós M Feito‐Rodríguez A Nuño‐González MD Montero‐Vega P Herranz‐Pinto

Categories: Specific diseases and patient groups

Adamantiades-Behçet’s disease (Behçet’s disease) and COVID-19

C.C. Zouboulis J.A.M. van Laar M. Schirmer G. Emmi F. Fortune A. Gül Y. Kirino E.‐S. Lee P.P. Sfikakis F. Shahram G.R. Wallace

Categories: Specific diseases and patient groups

Contemporary occurrence of Chilblain-like lesions and Pityriasis rosea during the COVID-19 pandemic

V. Piccolo, A. Bassi, G. Argenziano, C. Mazzatenta, M. Cutrone, I. Neri, R. Grimalt, T. Russo

Categories: Specific diseases and patient groups

Low incidence rate of respiratory and viral infections over 5 years of treatment with tildrakizumab in patients with moderate-to-severe psoriasis: pooled analysis from reSURFACE 1 and reSURFACE 2 phase 3 trials

D. Thaçi, D. Jullien, A. Egeberg, J.M. Carrascosa, J.J. Wu, I. Pau-Charles, P. Gisondi

Categories: Specific diseases and patient groups

Androgenetic alopecia in women and men is not related to COVID-19 infection severity: A prospective cohort study of hospitalized COVID-19 patients

Shatila Torabi, Mahnaz Mozdourian, Roxana Rezazadeh, Abolfazl Payandeh, Shapour Badiee, Emadodin Darchini-Maragheh

Categories: Teledermatology

A new virtual inpatient dermatology electronic referral service: a timely solution in the COVID-19 pandemic and beyond?

A Lowe A Pararajasingam FM Ali S Dawood CD Lowe NM Stone